Acrivon Therapeutics, Inc. ACRV
Set alert
1.66 USD -0.10 -5.68%
At close · Oct 30
1.70 +0.04 +2.41%
After hours · Oct 30, 5:27 PM ET
1.65 Day range 1.76
1.29 52-week range 3.01
- YTD
- -31.12%
- 1 year
- -14.43%
- Open
- 1.74
- Prev close
- 1.76
- Mkt cap
- 71.14M
- Vol
- 165.74K
- Avg vol
- 300.34K
- EPS
- -1.88
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.65
- High
- 1.76
- Forward P/E
- -2.31
- Beta
- 0.00
- Short ratio
- 15.38
- Inst. own
- 75.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 7.44
- 200-d avg
- 7.65
- 1y target
- 21.11
Financial health
Altman Z-Score
-2.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -1.2×
FY 2020 5y median -2.9× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 0.8×
FY 2020 5y median 0.9× FY 2025
P/FCF -1.4×
FY 2020 5y median -3.4× FY 2025
EV/EBITDA -0.7×
FY 2020 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -70.4%
FY 2020 5y median -29.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -69.2%
FY 2020 5y median -45.6% FY 2025
ROIC -73.0%
FY 2020 5y median -49.4% FY 2025
ROA -60.1%
FY 2020 5y median -41.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 5.7%
FY 2020 FY 2025
EPS (diluted) 3.8%
FY 2020 FY 2025
Free Cash Flow 4.5%
FY 2020 FY 2025
Financial Health
Current Ratio 7.7×
FY 2020 5y median 10.6× FY 2025
Quick Ratio 7.7×
FY 2020 5y median 10.6× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2020 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31